AVTE - Aerovate Therapeutics, Inc.

QQQ $ 473.83 $ 0.25 (0.05 %)

DIA $ 417.12 $ -0.12 (-0.03 %)

SPY $ 563.14 $ 0.23 (0.04 %)

TLT $ 100.82 $ -0.49 (-0.48 %)

GLD $ 237.35 $ -1.32 (-0.55 %)

Previous Close

$ 1.91

Open

Bid

$ 1.90 x 1,700

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.25 - $ 32.42

Volume

226,686

Average Volume

Market Cap

55.14M

Beta (5Y Monthly)

$ 1.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Aerovate Therapeutics To Explore Strategic...
07/08/2024 12:05:52

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), which previously announced it was halting enrollment and shutting down the Phase 3 p...

Watching Aerovate Therapeutics; Shares Mov...
06/21/2024 13:41:39

Evercore ISI Group Downgrades Aerovate The...
06/18/2024 17:55:22

Evercore ISI Group analyst Liisa Bayko downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Outperform to In-Line and lowers ...

Guggenheim Downgrades Aerovate Therapeutic...
06/18/2024 16:51:34

Guggenheim analyst Vamil Divan downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

Wells Fargo Downgrades Aerovate Therapeuti...
06/18/2024 14:28:26

Wells Fargo analyst Tiago Fauth downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Overweight to Equal-Weight and lowers th...

TD Cowen Downgrades Aerovate Therapeutics ...
06/18/2024 09:42:07

TD Cowen analyst Joseph Thome downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold.

nasdaq-surges-over-200-points-aarons-shares-jump

Nasdaq Surges Over 200 Points; Aaron's Sha...
06/17/2024 18:40:51

Jefferies Downgrades Aerovate Therapeutics...
06/17/2024 18:23:24

Jefferies analyst Eun Yang downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold and lowers the price target from ...

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

BTIG Downgrades Aerovate Therapeutics to N...
06/17/2024 17:07:31

BTIG analyst Julian Harrison downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

Crude Oil Rises 1%; Mustang Bio Shares Spi...
06/17/2024 16:16:09

why-is-small-cap-heart-disease-focused-aerovate-therapeutics-stock-plummeting-on-monday

Why Is Small Cap-Heart Disease Focused Aer...
06/17/2024 13:52:05

Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hy...

US Stocks Mixed; Dow Tumbles Over 100 Points
06/17/2024 13:40:41

Aerovate Therapeutics Announces 24-Week To...
06/17/2024 12:33:35

Trading Halt: Halted at 8:25:00 a.m. ET - ...
06/17/2024 12:25:04

Wedbush Reiterates Outperform on Aerovate ...
06/06/2024 13:53:21

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

Wedbush Reiterates Outperform on Aerovate ...
05/22/2024 14:58:46

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

Aerovate Therapeutics Presents Baseline Da...
05/21/2024 20:21:30

Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study ...

Wedbush Reiterates Outperform on Aerovate ...
05/14/2024 12:34:43

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.